semaglutide versus Comparison of body weight parameters for placebo semaglutide tirzepatide comparison tirzepatide vs
Description
Nat Metab 1, 5869 (2019)
Weeks 14: Adjustment Phase The body adapts to the medication
This is expected with any GLP-1 receptor agonist because slowing gastric emptying and suppressing appetite inevitably affects digestive function
This action may be particularly beneficial in the context of MASLD, where inflammation plays a pivotal role in disease progression
